))
Venture Capital & Biopharma: Jim Trenkle on Pioneering Health Innovation
Fetch error
Hmmm there seems to be a problem fetching this series right now.
Last successful fetch was on November 18, 2024 13:18 (
What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.
Manage episode 411349311 series 3535889
Indhold leveret af RealPharma. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af RealPharma eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Dive into the high-stakes world of Venture Capital in biopharma with Jim Trenkle! Have you ever wondered what it takes to turn groundbreaking scientific discoveries into life-saving treatments? What role do venture capitalists play in this thrilling journey from the lab to the clinic? This episode peels back the curtain on the biopharma venture capital scene, revealing the risks, rewards, and radical innovations driving the future of healthcare. Join hosts Dr. Na-Ri Oh and Ian Wendt as they explore with Jim the secrets of successful biopharma investments, the challenges of navigating the complex landscape of medical research funding, and the thrilling potential of the next big breakthroughs. Don't miss this conversation that could change the way you see medicine and innovation.
In this episode, Jim Trenkle, a partner at Nova Holdings, shares insights on venture capital in the biopharma industry. He explains the different stages of investment, from seed rounds to IPOs, and the role of venture capitalists in providing capital and expertise.
Jim discusses the current state of raising capital for biotech startups, including the impact of interest rates and market conditions. He also highlights the challenges and evaluation criteria in biotech VC, emphasizing the importance of a well-thought-out plan and addressing unmet needs.
Jim Trenkle also discusses his own career path and the importance of finding work that has a deeper impact. He shares his journey from being a medicinal chemist to venture capital, highlighting the value of lifelong learning and broadening one's impact. Trenkle also discusses the challenges and skills required in venture capital, emphasizing the need for humility and the ability to make decisions that have a real impact. He reflects on the lessons learned from the Theranos scandal and the role of venture capitalists in evaluating companies.
Trenkle explores the reasons behind company closures and failures in the biopharma industry and the potential for innovation and technological advances to shape the future of venture capital. He concludes with advice on career growth and the importance of following one's passion.
Chapters
00:00 Introduction of Jim Trankel
01:01 Understanding Venture Capital in BioPharma
07:59 The Current State of Raising Capital for Biotech Startups
11:23 The Landscape of Biotech Funding
16:25 Challenges and Evaluation in Biotech VC
23:16 What Does Good Look Like and Pitfalls to Avoid
31:19 Jim Trankel's Career Path
31:59 Career Path and Impact
35:19 Challenges and Skills in Venture
37:05 Evaluating Companies and Capital Allocators
38:23 Lessons from Theranos
46:01 Company Closures and Failures
52:42 The Future of VC in Biopharma
58:32 Advice and Mentors
Resources
- Jim Trenkle, PhD (LinkedIn)
- Novo Holdings
25 episoder
Del
